BACKGROUND: Several matrix metalloproteinases (MMPs) are involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). In mice, MMP-12 plays a crucial role in the development of cigarette smoke induced emphysema. A study was undertaken to investigate the role of MMP-12 in the development of COPD in human smokers. METHODS: Induced sputum samples were collected from patients with stable COPD (n = 28), healthy smokers (n = 14), never smokers (n = 20), and former smokers (n = 14). MMP-12 protein levels in induced sputum were determined by ELISA and compared between the four study groups. MMP-12 enzymatic activity in induced sputum was evaluated by casein zymography and by cleaving of a fluorescence quenched substrate. RESULTS: Median (IQR) MMP-12 levels were significantly higher in COPD patients than in healthy smokers, never smokers, and former smokers (17.5 (7.1-42.1) v 6.7 (3.9-10.4) v 4.2 (2.4-11.3) v 6.1 (4.5-7.6) ng/ml, p = 0.0002). MMP-12 enzymatic activity was significantly higher in patients with COPD than in controls (4.11 (1.4-8.0) v 0.14 (0.1-0.2) microg/microl, p = 0.0002). CONCLUSION: MMP-12 is markedly increased in induced sputum from patients with stable COPD compared with controls, suggesting a role for MMP-12 in the development of COPD in smokers.
BACKGROUND: Several matrix metalloproteinases (MMPs) are involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). In mice, MMP-12 plays a crucial role in the development of cigarette smoke induced emphysema. A study was undertaken to investigate the role of MMP-12 in the development of COPD in human smokers. METHODS: Induced sputum samples were collected from patients with stable COPD (n = 28), healthy smokers (n = 14), never smokers (n = 20), and former smokers (n = 14). MMP-12 protein levels in induced sputum were determined by ELISA and compared between the four study groups. MMP-12 enzymatic activity in induced sputum was evaluated by casein zymography and by cleaving of a fluorescence quenched substrate. RESULTS: Median (IQR) MMP-12 levels were significantly higher in COPDpatients than in healthy smokers, never smokers, and former smokers (17.5 (7.1-42.1) v 6.7 (3.9-10.4) v 4.2 (2.4-11.3) v 6.1 (4.5-7.6) ng/ml, p = 0.0002). MMP-12 enzymatic activity was significantly higher in patients with COPD than in controls (4.11 (1.4-8.0) v 0.14 (0.1-0.2) microg/microl, p = 0.0002). CONCLUSION:MMP-12 is markedly increased in induced sputum from patients with stable COPD compared with controls, suggesting a role for MMP-12 in the development of COPD in smokers.
Authors: F Le Naour; L Hohenkirk; A Grolleau; D E Misek; P Lescure; J D Geiger; S Hanash; L Beretta Journal: J Biol Chem Date: 2001-03-08 Impact factor: 5.157
Authors: A Efthimiadis; A Spanevello; Q Hamid; M M Kelly; M Linden; R Louis; M M M Pizzichini; E Pizzichini; C Ronchi; F Van Overvel; R Djukanović Journal: Eur Respir J Suppl Date: 2002-09
Authors: T Zheng; Z Zhu; Z Wang; R J Homer; B Ma; R J Riese; H A Chapman; S D Shapiro; J A Elias Journal: J Clin Invest Date: 2000-11 Impact factor: 14.808
Authors: Ladina Joos; Jian-Qing He; Megan B Shepherdson; John E Connett; Nicholas R Anthonisen; Peter D Paré; Andrew J Sandford Journal: Hum Mol Genet Date: 2002-03-01 Impact factor: 6.150
Authors: Richard E K Russell; Sarah V Culpitt; Carmen DeMatos; Louise Donnelly; Michael Smith; John Wiggins; Peter J Barnes Journal: Am J Respir Cell Mol Biol Date: 2002-05 Impact factor: 6.914
Authors: David G Morris; Xiaozhu Huang; Naftali Kaminski; Yanli Wang; Steven D Shapiro; Gregory Dolganov; Adam Glick; Dean Sheppard Journal: Nature Date: 2003-03-13 Impact factor: 49.962
Authors: Andrew Churg; Rong D Wang; Hsin Tai; Xiaoshan Wang; Changshi Xie; Jin Dai; Steven D Shapiro; Joanne L Wright Journal: Am J Respir Crit Care Med Date: 2003-01-09 Impact factor: 21.405
Authors: Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Joanne Sonstein; Jeffrey L Curtis; Uma S Sajjan Journal: Am J Pathol Date: 2011-11-08 Impact factor: 4.307
Authors: Michael P Nelson; Benjamin S Christmann; Chad W Dunaway; Alison Morris; Chad Steele Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-07-06 Impact factor: 5.464
Authors: F M Verhamme; L J M Seys; E G De Smet; S Provoost; W Janssens; D Elewaut; G F Joos; G G Brusselle; K R Bracke Journal: Mucosal Immunol Date: 2017-02-01 Impact factor: 7.313
Authors: John M Hartney; Jeanette Brown; Hong Wei Chu; Ling Yi Chang; Roberta Pelanda; Raul M Torres Journal: Am J Pathol Date: 2010-01-21 Impact factor: 4.307
Authors: Robert D Gray; Gordon MacGregor; Donald Noble; Margaret Imrie; Maria Dewar; A Christopher Boyd; J Alastair Innes; David J Porteous; Andrew P Greening Journal: Am J Respir Crit Care Med Date: 2008-06-19 Impact factor: 21.405
Authors: Satish K Madala; John T Pesce; Thirumalai R Ramalingam; Mark S Wilson; Samantha Minnicozzi; Allen W Cheever; Robert W Thompson; Margaret M Mentink-Kane; Thomas A Wynn Journal: J Immunol Date: 2010-02-24 Impact factor: 5.422